Suchergebnisse - "Goadsby, Peter"

PubPharm (18)

1

Insights into migraine attacks from neuroimaging

enthalten in: The Lancet. Neurology | 2023

von Messina, R. | Rocca, M. | Goadsby, P. | +1

2

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA : a phase 3, double-blind, randomised, placebo-controlled multicentre trial

enthalten in: The Lancet. Neurology | 2023

von Lipton, R. | Croop, R. | Stock, D. | +6

CommentIn: Lancet Neurol. 2023 Mar;22(3):190-191. - PMID 36804077

3

Calcitonin gene-related peptide-targeting drugs for migraine : how pharmacology might inform treatment decisions

enthalten in: The Lancet. Neurology | 2022

von Al-Hassany, L. | Goadsby, P. | Danser, A. | +1

CommentIn: Lancet Neurol. 2022 Mar;21(3):209-210. - PMID 35093197

4

Headache research in 2020 : disrupting and improving practice

enthalten in: The Lancet. Neurology | 2021

von Goadsby, P.

5

Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults : a double-blind, randomised phase 2b/3 trial

enthalten in: The Lancet. Neurology | 2020

von Goadsby, P. | Dodick, D. | Ailani, J. | +4

CommentIn: Lancet Neurol. 2020 Sep;19(9):712-713. - PMID 32822621

6

The need for continued care after sponsor closure - Authors' reply

enthalten in: The Lancet. Neurology | 2020

von Goadsby, P. | Rezai, A. | Dodick, D.

CommentOn: Lancet Neurol. 2019 Dec;18(12):1081-1090. - PMID 31701891

7

Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache : a double-blind, randomised controlled trial

enthalten in: The Lancet. Neurology | 2019

von Goadsby, P. | Sahai-Srivastava, S. | Kezirian, E. | +10

CommentIn: Lancet Neurol. 2019 Dec;18(12):1068-1069. - PMID 31701886

8

Safety and efficacy of AMG 334 for prevention of episodic migraine : a randomised, double-blind, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Neurology | 2016

von Sun, H. | Dodick, D. | Silberstein, S. | +8

CommentIn: Lancet Neurol. 2016 Apr;15(4):347-9. - PMID 26879278

9

New therapeutic approaches for the prevention and treatment of migraine

enthalten in: The Lancet. Neurology | 2015

von Diener, H. | Charles, A. | Goadsby, P. | +1

10

Site of effect of LY2951742 for migraine prophylaxis--authors' reply

enthalten in: The Lancet. Neurology | 2015

von Dodick, D. | Goadsby, P. | Spierings, E. | +3

CommentOn: Lancet Neurol. 2014 Sep;13(9):885-92. - PMID 25127173